1. Home
  2. CRBU vs ATLO Comparison

CRBU vs ATLO Comparison

Compare CRBU & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • ATLO
  • Stock Information
  • Founded
  • CRBU 2011
  • ATLO 1903
  • Country
  • CRBU United States
  • ATLO United States
  • Employees
  • CRBU N/A
  • ATLO N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • ATLO Major Banks
  • Sector
  • CRBU Health Care
  • ATLO Finance
  • Exchange
  • CRBU Nasdaq
  • ATLO Nasdaq
  • Market Cap
  • CRBU 179.7M
  • ATLO 180.3M
  • IPO Year
  • CRBU 2021
  • ATLO N/A
  • Fundamental
  • Price
  • CRBU $2.32
  • ATLO $20.84
  • Analyst Decision
  • CRBU Strong Buy
  • ATLO
  • Analyst Count
  • CRBU 3
  • ATLO 0
  • Target Price
  • CRBU $6.67
  • ATLO N/A
  • AVG Volume (30 Days)
  • CRBU 1.1M
  • ATLO 23.2K
  • Earning Date
  • CRBU 11-07-2025
  • ATLO 10-17-2025
  • Dividend Yield
  • CRBU N/A
  • ATLO 3.85%
  • EPS Growth
  • CRBU N/A
  • ATLO 82.22
  • EPS
  • CRBU N/A
  • ATLO 1.79
  • Revenue
  • CRBU $9,121,000.00
  • ATLO $60,568,000.00
  • Revenue This Year
  • CRBU $8.06
  • ATLO N/A
  • Revenue Next Year
  • CRBU N/A
  • ATLO N/A
  • P/E Ratio
  • CRBU N/A
  • ATLO $11.94
  • Revenue Growth
  • CRBU N/A
  • ATLO 18.60
  • 52 Week Low
  • CRBU $0.66
  • ATLO $15.75
  • 52 Week High
  • CRBU $3.00
  • ATLO $21.48
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 47.97
  • ATLO 55.69
  • Support Level
  • CRBU $2.35
  • ATLO $19.56
  • Resistance Level
  • CRBU $2.59
  • ATLO $21.00
  • Average True Range (ATR)
  • CRBU 0.21
  • ATLO 0.46
  • MACD
  • CRBU -0.06
  • ATLO 0.10
  • Stochastic Oscillator
  • CRBU 11.43
  • ATLO 63.16

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.

Share on Social Networks: